Hostname: page-component-55f67697df-4ks9w Total loading time: 0 Render date: 2025-05-10T06:10:49.039Z Has data issue: false hasContentIssue false
  • English
  • Français

Preventability of hospital onset bacteremia and fungemia: A pilot study of a potential healthcare-associated infection outcome measure

Published online by Cambridge University Press:  18 February 2019

Raymund B. Dantes Open the ORCID record for Raymund B. Dantes [Opens in a new window] ,
Clare Rock ,
Aaron M. Milstone ,
Jesse T. Jacob ,
Sheri Chernetsky-Tejedor ,
Anthony D. Harris  and
Surbhi Leekha
Raymund B. Dantes*
Affiliation:
Division of Hospital Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Clare Rock
Affiliation:
Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
Aaron M. Milstone
Affiliation:
Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland
Jesse T. Jacob
Affiliation:
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
Sheri Chernetsky-Tejedor
Affiliation:
Division of Hospital Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
Anthony D. Harris
Affiliation:
University of Maryland School of Medicine, Baltimore, Maryland, for the CDC Prevention Epicenter Program
Surbhi Leekha
Affiliation:
University of Maryland School of Medicine, Baltimore, Maryland, for the CDC Prevention Epicenter Program
*
Author for correspondence: Raymund B. Dantes, Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Hospital-onset bacteremia and fungemia (HOB), a potential measure of healthcare-associated infections, was evaluated in a pilot study among 60 patients across 3 hospitals. Two-thirds of all HOB events and half of nonskin commensal HOB events were judged as potentially preventable. Follow-up studies are needed to further develop this measure.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 40 , Issue 3 , March 2019 , pp. 358 - 361
Copyright
© 2019 by The Society for Healthcare Epidemiology of America. All rights reserved. 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Centers for Disease Control and Prevention. National and State Healthcare Associated Infections Progress Report. In: Division of Healthcare Quality Promotion NCEZID. Atlanta, GA: Centers for Disease Control and Prevention; 2016.Google Scholar
Healthcare-associated infections in the United States, 2006-2016: a story of progress. Centers for Disease Control and Prevention website. https://www.cdc.gov/hai/surveillance/data-reports/data-summary-assessing-progress.html. Published 2018. Accessed July 17, 2018.Google Scholar
Leekha, S, Li, S, Thom, KA, et al. Comparison of total hospital-acquired bloodstream infections to central line-associated bloodstream infections and implications for outcome measures in infection control. Infect Control Hosp Epidemiol 2013;34:984–986.CrossRefGoogle ScholarPubMed
Rock, C, Thom, KA, Harris, AD, et al. A multicenter longitudinal study of hospital-onset bacteremia: time for a new quality outcome measure? Infect Control Hosp Epidemiol 2016;37:143–148.CrossRefGoogle ScholarPubMed
Pronovost, P, Needham, D, Berenholtz, S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355:2725–2732.CrossRefGoogle ScholarPubMed
Blijlevens, NM, Donnelly, JP, De Pauw, BE.Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transpl 2000;25:1269–1278.CrossRefGoogle ScholarPubMed
Linsenmeyer, K, Gupta, K, Strymish, JM, Dhanani, M, Brecher, SM, Breu, AC. Culture if spikes? Indications and yield of blood cultures in hospitalized medical patients. J Hosp Med 2016;11:336–340.CrossRefGoogle ScholarPubMed
Alahmadi, YM, Aldeyab, MA, McElnay, JC, et al. Clinical and economic impact of contaminated blood cultures within the hospital setting. J Hosp Infect 2011;77:233–236.CrossRefGoogle ScholarPubMed
Waltzman, ML, Harper, M. Financial and clinical impact of false-positive blood culture results. Clin Infect Dis 2001;33:296–299.CrossRefGoogle ScholarPubMed
Towns, ML, Jarvis, WR, Hsueh, PR. Guidelines on blood cultures. J Microbiol Immunol Infect 2010;43:347–349.CrossRefGoogle ScholarPubMed